Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosis.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Vaccine

• Publication date

  2006-08-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2006.05.005PMID 16806606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Survey of caseous lymphadenitis seroprevalence in British terminal sire sheep breeds

  2004cited by this paper
• Prevalence of caseous lymphadenitis and usage of caseous lymphadenitis vaccines in sheep flocks.

  2003cited by this paper
• Prevalence of caseous lymphadenitis and usage of caseous lymphadenitis vaccines in sheep flocks.

  2003cited by this paper
• 118. Post-mortem and serological examinations of sheep in three flocks affected with caseous lymphadenitis

  2002cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Characterization of United Kingdom Isolates ofCorynebacterium pseudotuberculosis Using Pulsed-Field Gel Electrophoresis

  2000cited by this paper
• Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D.

  1999cited by this paper
• Targeting Improves the Efficacy of a DNA Vaccine against Corynebacterium pseudotuberculosis in Sheep

  1999cited by this paper
• Vaccine Potential of Attenuated Mutants ofCorynebacterium pseudotuberculosis in Sheep

  1998cited by this paper
• Caseous lymphadenitis: an increasing cause for concern.

  1997cited by this paper
• Attenuation and vaccine potential of aroQ mutants of Corynebacterium pseudotuberculosis

  1997cited by this paper
• A Corynebacterium pseudotuberculosis bacterin with muramyl dipeptide induces antibody titers, increases the time of onset, and decreases naturally occurring external abscesses in sheep and goats

  1996cited by this paper
• The spread of Corynebacterium pseudotuberculosis infection to unvaccinated and vaccinated sheep.

  1995cited by this paper
• Caseous lymphadenitis vaccine development: site-specific inactivation of the Corynebacterium pseudotuberculosis phospholipase D gene.

  1995cited by this paper
• Protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant Corynebacterium pseudotuberculosis

  1994cited by this paper
• New infection with Corynebacterium pseudotuberculosis reduces wool production.

  1994cited by this paper
• Identification of a novel antigen from Corynebacterium pseudotuberculosis that protects sheep against caseous lymphadenitis

  1994cited by this paper
• Serological response of vaccinated sheep after challenge with Corynebacterium pseudotuberculosis.

  1992cited by this paper
• Immunisation against ovine caseous lymphadenitis: comparison of Corynebacterium pseudotuberculosis vaccines with and without bacterial cells.

  1991cited by this paper
• Immunisation against ovine caseous lymphadenitis: correlation between Corynebacterium pseudotuberculosis toxoid content and protective efficacy in combined clostridial-corynebacterial vaccines.

  1991cited by this paper
• A field trial to evaluate a whole cell vaccine for the prevention of caseous lymphadenitis in sheep and goat flocks.

  1991cited by this paper
• Immunisation against ovine caseous lymphadenitis: efficacy of monocomponent Corynebacterium pseudotuberculosis toxoid vaccine and combined clostridial-corynebacterial vaccines.

  1991cited by this paper
• Immunisation against ovine caseous lymphadenitis: efficacy of monocomponent Corynebacterium pseudotuberculosis toxoid vaccine and combined clostridial-corynebacterial vaccines.

  1991cited by this paper
• Caseous lymphadenitis in goats in England

  1990cited by this paper
• Effect of muramyl dipeptide on immunogenicity of Corynebacterium pseudotuberculosis whole-cell vaccines in mice and lambs.

  1990cited by this paper
• Use of a toxoid vaccine to protect goats against intradermal challenge exposure to Corynebacterium pseudotuberculosis.

  1986cited by this paper
• Pathogenesis of caseous lymphadenitis in sheep and goats.

  1986cited by this paper
• Immunogenicity of Corynebacterium pseudotuberculosis and the effect of adjuvants in mice.

  1985cited by this paper
• Comparison of protection induced in lambs by Corynebacterium pseudotuberculosis whole cell and cell wall vaccines.

  1984cited by this paper
• Ovine caseous lymphadenitis: disease prevalence, lesion distribution, and thoracic manifestations in a population of mature culled sheep from western United States.

  1984cited by this paper
• Visceral caseous lymphadenitis in thin ewe syndrome: isolation of Corynebacterium, Staphylococcus, and Moraxella spp from internal abscesses in emaciated ewes.

  1979cited by this paper
• Action of Corynebacterium ovis exotoxin on endothelial cells of blood vessels

  1978cited by this paper
• Effects of thin ewe syndrome on reproductive efficiency.

  1977cited by this paper
• Studies on the enhancement of immunity to Corynebacterium pseudotuberculosis.

  1973cited by this paper
• Immune response of merino sheep to inactivated Corynebacterium pseudotuberculosis vaccine.

  1972cited by this paper
• Examination by electron microscopy of the interaction between peritoneal phagocytes and Corynebacterium ovis.

  1972cited by this paper
• Adoptive transfer of immunity in experimental Corynebacterium ovis infection.

  1970cited by this paper
• Relationship of Corynebacterium pseudotuberculosis protoplasmic toxins to the exotoxin.

  1970cited by this paper
• The pathogenic action of the exotoxin of Corynebacterium ovis.

  1965cited by this paper
• A Toxic Lipid from the Surface of Corynebacterium ovis

  1956cited by this paper
• The inter-relations of Corynebacterium ovis, Corynebacterium diphtheriæ, and certain diphtheroid strains derived from the human nasopharynx

  1934cited by this paper

• Antimicrobial Susceptibility and Molecular Characterization of Corynebacterium pseudotuberculosis Isolates Recovered From Caseous Lymphadenitis in Sheep

  2025cites this paper
• Etiological Agent, Pathogenesis, Diagnosis, Treatment, Measures for Prevention and Control of Caseous Lymphadenitis Disease in the Small Ruminants with Special Reference to Sheep

  2024cites this paper
• First Trial of a Novel Caseous Lymphadenitis Inactivated Vaccine in South Korea: Experimental Evaluation across Various Animal Models

  2024cites this paper
• Caseous lymphadenitis: virulence factors, pathogenesis and vaccines. Review

  2022cites this paper
• Linfadenitis caseosa: factores de virulencia, patogénesis y vacunas. Revisión

  2022cites this paper
• Vaccines for caseous lymphadenitis: up-to-date and forward-looking strategies

  2021cites this paper
• Assessment of the acid phosphatase CP01850 from Corynebacterium pseudotuberculosis in DNA and subunit vaccine formulations against caseous lymphadenitis

  2020cites this paper
• The Relevance of Caseous Lymphadenitis as a Cause of Culling in Adult Sheep

  2020cites this paper
• Laser ablation and management of a retropharyngeal abscess caused by Corynebacterium pseudotuberculosis in a ram

  2020cites this paper
• Response with TH1 profile obtained in vaccine formulation against Caseous Lymphadenitis in animal model C57 Black/6

  2019cites this paper
• Responses of female reproductive hormones and histopathology in the reproductive organs and associated lymph nodes of Boer does challenged with Corynebacterium pseudotuberculosis and its immunogenic corynomycolic acid extract.

  2019cites this paper
• Association of Corynebacterium pseudotuberculosis recombinant proteins rCP09720 or rCP01850 with rPLD as immunogens in caseous lymphadenitis immunoprophylaxis.

  2018cites this paper
• A Trial for Vaccination of Sheep against Caseous Lymphadentitis Using Oil Adjuvent Bacterin Enhanced by Bacillus Calmette-Guerin Vaccine

  2018influential citation
• Humoral immune response of pregnant goats to two Corynebacterium pseudotuberculosis bacterin formulations

  2018cites this paper
• Recombinant M. bovis BCG expressing the PLD protein promotes survival in mice challenged with a C. pseudotuberculosis virulent strain.

  2018cites this paper
• The Epidemiology and Pathophysiology of Caseous Lymphadenitis : A Review

  2018cites this paper
• BIOTECHNOLOGICAL POTENTIAL OF THE USE OF SYNTHETIC PEPTIDES IN VACCINE FORMULATIONS AGAINST CASEOUS LYMPHADENITS

  2018cites this paper
• Immune-Informatic Analysis and Design of Peptide Vaccine From Multi-epitopes Against Corynebacterium pseudotuberculosis

  2018cites this paper
• Biomarkers of the Caseous Lymphadenitis in Sheep by NMR-BasedMetabolomics

  2017cites this paper
• Caseous lymphadenitis in small ruminants: An overview on reproductive implications

  2017cites this paper
• A case of kidney infection by Corynebacterium pseudotuberculosis in sheep.

  2017cites this paper
• Study of the Immune Response Induced by an Attenuated Strain of Corynebacterium pseudotuberculosis in Sheep Reared Under Extensive System

  2017cites this paper
• Recombinant esterase from Corynebacterium pseudotuberculosis in DNA and subunit recombinant vaccines partially protects mice against challenge

  2017cites this paper
• Corynebacterium pseudotuberculosis biovar equi infection in horses: transmission and diagnosis

  2016cites this paper
• Diagnostic comparison of Corynebacterium pseudotuberculosis through microbiological culture and PCR in sheep samples

  2016cites this paper
• Influence of Corynebacterium pseudotuberculosis infection on level of acute phase proteins in goats

  2016cites this paper
• CASEOUS LYMPHADENITIS IN IRAQI SHEEP AND ASSESSMENT OF VACCINATION WITH COMMERCIAL VACCINE

  2016cites this paper
• Vaccination against Corynebacterium pseudotuberculosis infections controlling caseous lymphadenitis (CLA) and oedematousskin disease

  2016cites this paper
• Comparison of the efficiency of concentrated soluble recombinant phospholipase D and natural phospholipase D enzymes

  2016cites this paper
• Field evaluation of inactivated Corynebacterium ovis vaccine in sheep prepared from a local isolate

  2016cites this paper
• Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain.

  2016cites this paper
• Lack of interference with diagnostic testing for tuberculosis in goats experimentally exposed to Corynebacterium pseudotuberculosis.

  2015cites this paper
• Vaccination schedules in small ruminant farms.

  2015cites this paper
• Immunological characterization of diphtheria toxin recovered from Corynebacterium pseudotuberculosis

  2015cites this paper
• Verkäsende Lymphadenitis bei kleinen Wiederkäuern in Ägypten

  2014cites this paper
• Single-point mutation as a molecular tool for preparation of recombinant vaccine against Caseous Lymphadenitis

  2014cites this paper
• In Silico Analysis of Acinetobacter baumannii Phospholipase D as a Subunit Vaccine Candidate

  2014cites this paper
• Caseous lymphadenitis in small ruminants in Egypt

  2014cites this paper
• The vaccine potential of Bordetella pertussis biofilm-derived membrane proteins

  2014cites this paper
• RESEARCH OPINIONS IN ANIMAL & VETERINARY SCIENCES Responses of inflammatory cytokines in non-pregnant Boer does inoculated with Corynebacterium pseudotuberculosis via various routes

  2014cites this paper
• Management of a caseous lymphadenitis outbreak in a new Iberian ibex (Capra pyrenaica) stock reservoir

  2014cites this paper
• Morel's Disease and Caseous Lymphadenitis: a Literature Review with Special Reference to Saudi Arabia

  2014cites this paper
• Comparative genomic analyses of Corynebacterium pseudotuberculosis

  2013cites this paper
• TRIALS OF PREPARATION AND EVALUATION OF CORYNEBACTERIUM PSEUDOTUBERCULOSIS VACCINES IN SHEEP

  2013cites this paper
• Serological studies on Corynebacterium pseudotuberculosis infections in goats in Baden-Wuerttemberg (Germany) and seroreactions on antigens used for newly developed enzyme-linked immunosorbent assays (ELISA).

  2012cites this paper
• Corynebacterium pseudotuberculosis: Immunological Responses in Animal Models and Zoonotic Potential

  2012cites this paper
• CASEOUS LYMPHADENITIS: EPIDEMIOLOGY, DIAGNOSIS, AND CONTROL

  2011cites this paper
• Frequency of caseous lymphadenitis (CLA) in sheep slaughtered in an abattoir in Tabriz: comparison of bacterial culture and pathological study

  2011cites this paper
• Control of caseous lymphadenitis.

  2011cites this paper
• Identificação e caracterização de peptídeos bioativos através de Phage display usando genoma completo de Corynebacterium pseudotuberculosis

  2011cites this paper
• TRIALS OF PREPARATION AND EVALUATION OF CORYNEBACTERIUM PSEUDOTUBERCULOSIS VACCINES IN SHEEP

  2011cites this paper
• A Novel Comparative Genomics Analysis for Common Drug and Vaccine Targets in Corynebacterium pseudotuberculosis and other CMN Group of Human Pathogens

  2011cites this paper
• Pilot immunization of mice infected with an equine strain of Corynebacterium pseudotuberculosis.

  2010cites this paper
• Infeccoes por Corynebacterium pseudotuberculosis em animais de producao

  2010cites this paper
• The control of Corynebacterium pseudotuberculosis infection in sheep flocks: a mathematical model of the impact of vaccination, serological testing, clinical examination and lancing of abscesses.

  2010cites this paper
• The Epidemiology and Control of Caseous Lymphadenitis in Australian Sheep Flocks

  2010cites this paper
• Control of caseous lymphadenitis in six sheep flocks using clinical examination and regular ELISA testing

  2010cites this paper
• Corynebacterium and Arcanobacterium

  2010cites this paper
• Iron-dependent regulation of gene expression in Corynebacterium pseudotuberculosis

  2009influential citation
• Antigens of Corynebacterium pseudotuberculosis and prospects for vaccine development

  2009cites this paper
• Evaluation of the humoral and cellular immune response to different antigens of Corynebacterium pseudotuberculosis in Canindé goats and their potential protection against caseous lymphadenitis.

  2008cites this paper
• Respiratory disease in sheep

  2008cites this paper
• Corynebacterium pseudotuberculosis and its role in ovine caseous lymphadenitis.

  2007cites this paper
• Acute phase protein response in an experimental model of ovine caseous lymphadenitis

  2007influential citation
• The role of corynebacterial phospholipase D vaccine in activation of macrophages

  2007influential citation